Pre-Prints:

Bartsch et al.
bioRxiv 2022

Comprehensive antibody profiling of mRNA vaccination in children

Canaday et al.
medRxiv 2021

Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination

Kenney et al.
bioRxiv 2021

Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection

Calvet-Mirabent et al.
bioRxiv 2021

Tailored DC induce protective HIV-1 specific polyfunctional CD8+ T cells in the lymphoid tissue from humanized mice

Hauser et al.
bioRxiv 2020

Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies

Publications:

Casazza et al.
Nature Med. 2022

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Hauser et al.
Cell Rep. 2022

Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif

Vanuytsel et al.
Nature Comm. 2020

Multi-modal profiling of human fetal liver-derived hematopoetic stem cells reveals the molecular signature of engraftment potential

Naranbhai et al.
Cell 2022

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

Canaday et al.
Clin. Infect Dis. 2022

Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination

Garcia-Beltran et al.
Cell 2022

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS- CoV-2 Omicron variant

Naranbhai et al.
Cancer Cell 2021

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer

Naranbhai et al.
J Infect Dis 2021

Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines

Bowes et al.
Radiother Oncol 2021

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy

Naranbhai et al.
J Clin Oncol 2021

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Oyebanji et al.
Aging Clin Exp Res 2021

Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?

Feldman et al.
Sci Imm 2021

Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain

Phelps et al.
Front Immunol 2021

Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis

Garcia-Beltran et al.
Front Immunol 2021

Innate immune reconstitution in humanized bone marrow-liver-thymus (HuBLT) mice governs adaptive cellular immune function and responses to HIV-1 infection

Garcia-Beltran et al.
Cell 2021

Multiple circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Schiff et al.
Scientific Reports 2021

T cell-tropic HIV efficiently infects alveolar macrophages through contact with infected CD4+T cells.

Yousif et al.
Immunity 2020

The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells

Kisalu et al.
JCI Insight 2020

Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

Crawford et al.
Viruses 2020

Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays

Keating et al.
Journal of Proteome Research 2020

Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens.

Huang et al.
PLoS One 2019

Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.

van den Berg et al.
Molecular Therapy Methods Clinical Development 2019

AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.

Welles et al.
PLoS Pathogens 2018

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.

Lin et al.
Retrovirology 2018

Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.

Brady et al.
Immunological Reviews 2017

Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.

Payne et al.
Molecular Therapy Methods Clinical Development 2016

Multilineage transduction of resident lung cells in vivo by AAV2/8 for alpha1-antitrypsin gene therapy.

Thomas et al.
Experimental Hematology 2016

Insulin-like growth factor 2 modulates murine hematopoietic stem cell maintenance through upregulation of p57.

Akkina et al.
AIDS Research and Human Retroviruses 2016

Improvements and Limitations of Humanized Mouse Models for HIV Research.

Saunders et al.
Journal of Virology 2015

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.

Deal et al.
Current Opinion in HIV & AIDS 2015

Vectored antibody gene delivery for the prevention or treatment of HIV infection.

de Jong et al.
Science Translational Medicine 2014

Broadly neutralizing antibodies abrogate established hepatitis C virus infection.

O'Connell et al.
PLoS ONE 2010

Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations.

O'Connell et al.
PNAS 2010

MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.

Balazs et al.
Blood 2006

Endothelial Protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow.

Balooch et al.
J. Biomed. Mater. Res. 1998

Viscoelastic properties of demineralized human dentin measured in water with atomic force microscope (AFM)-based indentation.